Sex differences in Alzheimer’s disease: plasma MMP-9 and markers of disease severity

BACKGROUND: Studies have reported higher plasma matrix metalloproteinase-9 (MMP-9) levels in mild cognitive impairment (MCI) and Alzheimer’s disease (AD). Despite evidence that MMP-9 activity and its influence on AD pathophysiology may be modulated by sex hormones, sex differences in the association...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsiknia, Amaryllis A., Sundermann, Erin E., Reas, Emilie T., Edland, Steven D., Brewer, James B., Galasko, Douglas, Banks, Sarah J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628176/
https://www.ncbi.nlm.nih.gov/pubmed/36324151
http://dx.doi.org/10.1186/s13195-022-01106-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628176/
https://www.ncbi.nlm.nih.gov/pubmed/36324151
http://dx.doi.org/10.1186/s13195-022-01106-4

Ejemplares similares